143 related articles for article (PubMed ID: 1332945)
1. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
J Biol Chem; 1992 Dec; 267(34):24153-6. PubMed ID: 1332945
[TBL] [Abstract][Full Text] [Related]
2. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
3. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
Kosugi S; Kohn LD; Akamizu T; Mori T
Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
[TBL] [Abstract][Full Text] [Related]
4. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
5. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
[TBL] [Abstract][Full Text] [Related]
6. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
[TBL] [Abstract][Full Text] [Related]
7. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
Kosugi S; Shenker A; Mori T
FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
[TBL] [Abstract][Full Text] [Related]
9. The first cytoplasmic loop of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
Kosugi S; Mori T
FEBS Lett; 1994 Mar; 341(2-3):162-6. PubMed ID: 8137933
[TBL] [Abstract][Full Text] [Related]
10. Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies.
Kosugi S; Ban T; Akamizu T; Kohn LD
Biochem Biophys Res Commun; 1992 Dec; 189(3):1754-62. PubMed ID: 1336379
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
Hidaka A; Minegishi T; Kohn LD
Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains.
Kosugi S; Ban T; Akamizu T; Kohn LD
J Biol Chem; 1991 Oct; 266(29):19413-8. PubMed ID: 1655787
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
Kosugi S; Ban T; Akamizu T; Kohn LD
Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
[TBL] [Abstract][Full Text] [Related]
15. Cysteine-699, a possible palmitoylation site of the thyrotropin receptor, is not crucial for cAMP or phosphoinositide signaling but is necessary for full surface expression.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1996 Apr; 221(3):636-40. PubMed ID: 8630013
[TBL] [Abstract][Full Text] [Related]
16. Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction.
Nagayama Y; Rapoport B
Endocrinology; 1992 Aug; 131(2):548-52. PubMed ID: 1322272
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction by the human thyrotropin receptor: studies on the role of individual amino acid residues in the carboxyl terminal region of the third cytoplasmic loop.
Chazenbalk GD; Nagayama Y; Wadsworth H; Russo D; Rapoport B
Mol Endocrinol; 1991 Oct; 5(10):1523-6. PubMed ID: 1663578
[TBL] [Abstract][Full Text] [Related]
18. Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction.
Akamizu T; Inoue D; Kosugi S; Ban T; Kohn LD; Imura H; Mori T
Endocr J; 1993 Jun; 40(3):363-72. PubMed ID: 7920890
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin activates both the cyclic AMP and the PIP2 cascades in CHO cells expressing the human cDNA of TSH receptor.
Van Sande J; Raspé E; Perret J; Lejeune C; Maenhaut C; Vassart G; Dumont JE
Mol Cell Endocrinol; 1990 Nov; 74(1):R1-6. PubMed ID: 2178105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
